Janux Therapeutics JANX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$113.63M-64.7% | -$68.99M-18.4% | -$58.29M+7.6% | -$63.06M-93.0% | ||
| $2.03M-1.5% | $2.06M+5.4% | $1.96M+132% | $841K+644% | ||
| $40.22M+21.8% | $33.02M+65.1% | $20.01M+16.3% | $17.2M+149% | ||
| -$82.24M-87.7% | -$43.81M+13.4% | -$50.58M-17.8% | -$42.92M-153% | ||
| $1.04M+191% | $359K-80.6% | $1.85M-71.3% | $6.45M+335% | ||
| —— | —— | —— | $59.87M+117% | ||
| $4.95M-99.3% | $713.24M+1,098% | $59.55M+11,810% | $500K-99.9% | ||
| -$382.22M-193% | $411.4M— | —— | —— | ||
| -$83.28M-88.5% | -$44.17M+15.7% | -$52.43M-6.2% | -$49.37M-167% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Janux Therapeutics generate?
- Janux Therapeutics (JANX) generated -$77.5M in operating cash flow over the trailing twelve months.
- What is Janux Therapeutics's free cash flow?
- After $945.0K of capital expenditures, Janux Therapeutics's free cash flow was -$78.5M over the trailing twelve months, down 68.7% year over year.
- Where does Janux Therapeutics's cash flow data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
